NRX Pharmaceuticals, Inc. Income (Loss) from Equity Method Investments
NRX Pharmaceuticals, Inc. (NRXP) reported Income (Loss) from Equity Method Investments of $3.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-14
- NRX Pharmaceuticals, Inc. income (loss) from equity method investments for the quarter ending 2026-06-30 was $3.00K.
- NRX Pharmaceuticals, Inc. income (loss) from equity method investments for the quarter ending 2026-03-31 was $2.00K.
- NRX Pharmaceuticals, Inc. income (loss) from equity method investments for the quarter ending 2025-06-30 was $0.00.
- NRX Pharmaceuticals, Inc. income (loss) from equity method investments for the quarter ending 2025-03-31 was $0.00.
- NRX Pharmaceuticals, Inc. income (loss) from equity method investments for fiscal 2024 was $0.00.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|---|
| 2026-06-30 | $3.00K 10-Q · filed 2026-08-14 | $5.00K 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $35.00K 10-Q · filed 2026-08-14 | -$35.00K 10-K · filed 2026-03-23 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |